What should I do if ritexitinib causes seborrheic alopecia?
Ritlecitinib is a targeted drug mainly used to treat specific types of immune system-related diseases, such as atopic dermatitis. One possible side effect is seborrheic alopecia, which usually manifests as increased oil production on the scalp and thinning or loss of hair. The reason for this side effect may be that the drug affects the scalp, causing hair follicles to be inhibited, thereby affecting the hair growth cycle.
If patients find that their hair loss symptoms worsen while taking rituxitinib, they should inform their doctor in time. The doctor may evaluate a patient's hair loss and determine whether the medication dose needs to be adjusted or discontinued. Sometimes, lowering the dose of a medication can reduce the occurrence of side effects and thereby reduce the symptoms of seborrheic alopecia. The doctor may recommend a more appropriate treatment plan to help the patient alleviate the hair loss problem. ,
For mild cases of seborrheic alopecia, patients can make some lifestyle adjustments to relieve symptoms. For example, keep your scalp clean, use an appropriate shampoo, and avoid over-irritating your scalp. In addition, reducing physical stimulation to the hair, such as avoiding frequent combing or pulling the hair, can also help reduce hair loss. During the treatment process, patients should avoid using too many chemical products or drugs on their own to avoid causing greater damage to the scalp.
Finally, seborrheic alopecia is one of the common side effects of many drugs. Hair loss symptoms usually improve after stopping the drug or adjusting the treatment plan. If hair loss is severe and affects the patient's daily life or mental health, the doctor may recommend some medications or treatments, such as hair growth drugs (such as minoxidil) to promote hair regrowth. At the same time, patients can also use psychological counseling and support to reduce the negative impact of hair loss on their emotions and help restore their self-confidence.
Reference materials:https://www.litfulo.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)